Intuitive Surgical [ISRG] vs West Pharmaceutical [WST] Detailed Stock Comparison

Intuitive Surgical, Inc.

NASDAQ
Loading...

West Pharmaceutical Services Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Intuitive Surgical, Inc. wins in 9 metrics, West Pharmaceutical Services Inc. wins in 11 metrics, with 0 ties. West Pharmaceutical Services Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Intuitive Surgical, Inc. West Pharmaceutical Services Inc. Better
P/E Ratio (TTM) 54.97 40.99 West Pharmaceutical Services Inc.
Price-to-Book Ratio 8.99 6.94 West Pharmaceutical Services Inc.
Debt-to-Equity Ratio 0.95 10.73 Intuitive Surgical, Inc.
PEG Ratio 3.30 0.74 West Pharmaceutical Services Inc.
EV/EBITDA 43.46 24.63 West Pharmaceutical Services Inc.
Profit Margin (TTM) 28.38% 16.85% Intuitive Surgical, Inc.
Operating Margin (TTM) 30.16% 21.70% Intuitive Surgical, Inc.
EBITDA Margin (TTM) 30.16% 21.70% Intuitive Surgical, Inc.
Return on Equity 16.69% 19.13% West Pharmaceutical Services Inc.
Return on Assets (TTM) 9.39% 11.21% West Pharmaceutical Services Inc.
Free Cash Flow (TTM) $2.49B $468.90M Intuitive Surgical, Inc.
Dividend Yield N/A 0.46% N/A
1-Year Return -19.74% 48.18% West Pharmaceutical Services Inc.
Price-to-Sales Ratio (TTM) 15.93 6.72 West Pharmaceutical Services Inc.
Enterprise Value $154.62B $21.43B Intuitive Surgical, Inc.
EV/Revenue Ratio 15.36 6.65 West Pharmaceutical Services Inc.
Gross Profit Margin (TTM) 66.44% 35.08% Intuitive Surgical, Inc.
Revenue per Share (TTM) $28 $45 West Pharmaceutical Services Inc.
Earnings per Share (Diluted) $8.21 $7.47 Intuitive Surgical, Inc.
Beta (Stock Volatility) 1.68 1.15 West Pharmaceutical Services Inc.
Short % of Float 1.91% 4.38% Intuitive Surgical, Inc.

Intuitive Surgical, Inc. vs West Pharmaceutical Services Inc. Stock Performance Analysis

Loading Price Chart...

ISRG
WST

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Intuitive Surgical, Inc.1.34%-0.49%-1.09%-13.84%-25.55%-25.88%
West Pharmaceutical Services Inc.0.79%3.65%9.42%37.92%21.91%19.91%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Intuitive Surgical, Inc.-19.74%24.81%40.32%476.52%974.11%3,431.44%
West Pharmaceutical Services Inc.48.18%-9.18%-6.66%345.01%1,441.58%1,794.12%

Performance & Financial Health Analysis: Intuitive Surgical, Inc. vs West Pharmaceutical Services Inc.

MetricISRGWST
Market Information
Market Cap i$170.06B$22.07B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,113,3471,085,830
90 Day Avg. Volume i1,799,766930,327
Last Close$416.55$331.43
52 Week Range$396.68 - $603.88$206.80 - $336.82
% from 52W High-31.02%-1.60%
All-Time High$616.00 (Jan 20, 2025)$475.35 (Sep 06, 2021)
% from All-Time High-32.38%-30.28%
Growth Metrics
Quarterly Revenue Growth0.19%0.21%
Quarterly Earnings Growth0.16%0.55%
Financial Health
Profit Margin (TTM) i0.28%0.17%
Operating Margin (TTM) i0.30%0.22%
Return on Equity (TTM) i0.17%0.19%
Debt to Equity (MRQ) i0.9510.73
Cash & Liquidity
Book Value per Share (MRQ)$50.19$44.11
Cash per Share (MRQ)$16.71$7.38
Operating Cash Flow (TTM) i$3.03B$715.30M
Levered Free Cash Flow (TTM) i$2.27B$275.66M
Dividends
Last 12-Month Dividend Yield iN/A0.46%
Last 12-Month Dividend iN/A$1.07

Valuation & Enterprise Metrics Analysis: Intuitive Surgical, Inc. vs West Pharmaceutical Services Inc.

MetricISRG (Apr 24, 2026)WST (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i54.9740.99
Forward P/E i39.4932.05
PEG Ratio i3.300.74
Price to Sales (TTM) i15.936.72
Price to Book (MRQ) i8.996.94
Market Capitalization
Market Capitalization i$170.06B$22.07B
Enterprise Value i$154.62B$21.43B
Enterprise Value Metrics
Enterprise to Revenue i15.366.65
Enterprise to EBITDA i43.4624.63
Risk & Other Metrics
Beta i1.681.15
Book Value per Share (MRQ) i$50.19$44.11

Financial Statements Comparison: Intuitive Surgical, Inc. vs West Pharmaceutical Services Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricISRG (2025)WST (2025)
Revenue/Sales i10.06B3.07B
Cost of Goods Sold i3.42B1.97B
COGS % of Revenue i34.0%64.1%
Gross Profit i6.64B1.10B
Gross Margin i66.0%35.9%
Research & Development i1.31B74.30M
Operating Income (EBIT) i2.95B636.10M
Operating Margin i29.3%20.7%
EBITDA i3.62B822.70M
EBITDA Margin i36.0%26.8%
Pre-Tax Income i3.31B600.90M
Pre-Tax Income % of Revenue i32.9%19.5%
Income Tax i434.80M121.60M
Income Tax % of Revenue i4.3%4.0%
Net Income (Profit) i2.88B493.70M
Profit Margin i28.6%16.1%

Balance Sheet & Liquidity Metrics

MetricISRG (2025)WST (2025)
Cash & Equivalents i3.37B791.30M
Total Current Assets i9.78B1.98B
Total Current Assets % of Revenue i97.2%64.4%
Total Current Liabilities i2.01B654.90M
Total Current Liabilities % of Revenue i19.9%21.3%
Long-Term Debt iN/A298.40M
Long-Term Debt % of Revenue i0.0%9.7%
Total Shareholders Equity i17.94B3.18B
Retained Earnings i7.01B4.37B
Retained Earnings % of Revenue i69.7%142.3%
Property, Plant & Equipment i2.10B296.40M

Cash Flow Statement Comparison

MetricISRG (2025)WST (2025)
Operating Cash Flow i3.28B753.00M
Operating Cash Flow % of Revenue i32.5%24.5%
Capital Expenditures i-539.80MN/A
Free Cash Flow i2.49B468.90M
FCF Margin i24.7%15.3%
Debt Repayment iN/A-1.10M
Common Stock Repurchase i-2.30B-136.80M

Short Interest & Institutional Ownership Analysis

MetricISRGWST
Shares Short i6.75M2.66M
Short Ratio i4.193.18
Short % of Float i1.91%4.38%
Shares Outstanding i355.10M70.90M
Float Shares i352.94M70.15M
% Held by Insiders i0.56%0.64%
% Held by Institutions i89.20%99.21%
% Held by Public i10.24%0.15%

Dividend Analysis & Yield Comparison: Intuitive Surgical, Inc. vs West Pharmaceutical Services Inc.

MetricISRGWST
Last 12-Month Dividend iN/A$1.07
Last 12-Month Dividend Yield iN/A0.46%
3-Year Avg Annual Dividend iN/A$0.82
3-Year Avg Dividend Yield iN/A0.07%
3-Year Total Dividends iN/A$2.46
Ex-Dividend DateN/AJan 28, 2026